Sava Infond D.O.O. Trans Medics Group, Inc. Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Sava Infond D.O.O. holds 2,000 shares of TMDX stock, worth $244,420. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,200
9.09%
Holding current value
$244,420
Previous $148 Million
81.08%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding TMDX
# of Institutions
422Shares Held
29.7MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$439 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$323 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$158 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$129 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$117 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.89B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...